Physiomics Regulatory News (PYC)

Physiomics Plc

("Physiomics" or "the Company")

Physiomics to Present at BioTrinity 2017

Oxford, UK, 5th May 2017: Physiomics is pleased to announce that it will attend BioTrinity 2017. BioTrinity is one of Europe's leading Biopartnering and Investment Conferences, to be held on 8-10 May at the Novotel London West.

In addition to participating in a number of partnering meetings, Physiomics will present an update on its technology at the conference on Tuesday 9th May. Dr Jim Millen, CEO, will speak at 2.30pm during the Early Stage Showcase 4 session.

Founded and produced by OBN, BioTrinity is now in its 11th year. BioTrinity continues to grow with more than 1000 senior executives and decision makers from emerging and established companies across the life sciences sector and investment firms are expected to attend.

John Harris, CEO of OBN, said: "We are delighted that Physiomics will be presenting at BioTrinity this year. BioTrinity is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2017."

For further information on Physiomics please contact:

Physiomics plc

Dr Jim Millen, CEO

+44 (0)1865 784 980

WH Ireland Limited (NOMAD)

Katy Mitchell

+44 (0) 161 832 2174

Hybridan LLP (Broker)

Claire Louise Noyce

+44 (0) 203 764 2341

For further information on OBN please contact:

OBN

Jane O'Driscoll, Head of Events

+(44) 1235 420 875

Email: Jane.odriscoll.co.uk

Citigate Dewe Rogerson

Sylvie Berrebi

Tel: +44 (0)20 7282 1052

Email: Sylvie.berrebi @citigatedr.co.uk